|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
(Mark One)
þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 29, 2012
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________________ to _______________
Commission File Number: 000-01649
NEWPORT CORPORATION
(Exact name of registrant as specified in its charter)
Nevada |
|
94-0849175 |
(State or other jurisdiction of |
|
(IRS Employer Identification No.) |
incorporation or organization) |
|
|
1791 Deere Avenue, Irvine, California 92606
(Address of principal executive offices) (Zip Code)
(949) 863-3144
(Registrants telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ý No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ý No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer o |
Accelerated filer ý |
Non-accelerated filer o |
(Do not check if a smaller reporting company) Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No ý
As of October 26, 2012, 38,306,903 shares of the registrants sole class of common stock were outstanding.
|
|
|
NEWPORT CORPORATION
FORM 10-Q
|
Page | |
| ||
|
|
|
| ||
|
|
|
|
3 | |
|
|
|
|
Consolidated Balance Sheets as of September 29, 2012 and December 31, 2011 |
4 |
|
|
|
|
5 | |
|
|
|
|
6 | |
|
|
|
Managements Discussion and Analysis of Financial Condition and Results of Operations |
19 | |
|
|
|
28 | ||
|
|
|
30 | ||
|
|
|
| ||
|
|
|
31 | ||
|
|
|
31 | ||
|
|
|
33 | ||
|
| |
34 |
PART I FINANCIAL INFORMATION
NEWPORT CORPORATION
Consolidated Statements of Income and Comprehensive Income
(In thousands, except per share data)
(Unaudited)
|
|
Three Months Ended |
|
Nine Months Ended | ||||||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | ||||||||
|
|
2012 |
|
2011 |
|
2012 |
|
2011 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net sales |
|
$ |
142,881 |
|
|
$ |
125,598 |
|
|
$ |
453,703 |
|
|
$ |
384,141 |
|
Cost of sales |
|
80,073 |
|
|
69,815 |
|
|
255,943 |
|
|
210,810 |
| ||||
Gross profit |
|
62,808 |
|
|
55,783 |
|
|
197,760 |
|
|
173,331 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Selling, general and administrative expenses |
|
37,320 |
|
|
30,417 |
|
|
123,267 |
|
|
93,629 |
| ||||
Research and development expense |
|
12,869 |
|
|
11,152 |
|
|
40,319 |
|
|
31,785 |
| ||||
Operating income |
|
12,619 |
|
|
14,214 |
|
|
34,174 |
|
|
47,917 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Foreign currency translation gain from dissolution of subsidiary |
|
- |
|
|
- |
|
|
- |
|
|
7,198 |
| ||||
Gain on sale of investments |
|
950 |
|
|
- |
|
|
6,248 |
|
|
- |
| ||||
Interest and other expense, net |
|
(2,082 |
) |
|
(2,348 |
) |
|
(7,097 |
) |
|
(6,377 |
) | ||||
Income before income taxes |
|
11,487 |
|
|
11,866 |
|
|
33,325 |
|
|
48,738 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Income tax provision |
|
3,955 |
|
|
1,364 |
|
|
10,144 |
|
|
3,555 |
| ||||
Net income |
|
7,532 |
|
|
10,502 |
|
|
23,181 |
|
|
45,183 |
| ||||
Net loss attributable to non-controlling interests |
|
(104 |
) |
|
- |
|
|
(201 |
) |
|
- |
| ||||
Net income attributable to Newport Corporation |
|
$ |
7,636 |
|
|
$ |
10,502 |
|
|
$ |
23,382 |
|
|
$ |
45,183 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net income |
|
$ |
7,532 |
|
|
$ |
10,502 |
|
|
$ |
23,181 |
|
|
$ |
45,183 |
|
Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Foreign currency translation gains (losses) |
|
1,399 |
|
|
(5,514 |
) |
|
(499 |
) |
|
(8,649 |
) | ||||
Unrecognized net pension gains |
|
10 |
|
|
119 |
|
|
96 |
|
|
544 |
| ||||
Unrealized gains (losses) on marketable securities |
|
(13 |
) |
|
481 |
|
|
(120 |
) |
|
(281 |
) | ||||
Comprehensive income |
|
$ |
8,928 |
|
|
$ |
5,588 |
|
|
$ |
22,658 |
|
|
$ |
36,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Comprehensive loss attributable to non-controlling interests |
|
$ |
(94 |
) |
|
$ |
- |
|
|
$ |
(209 |
) |
|
$ |
- |
|
Comprehensive income attributable to Newport Corporation |
|
9,022 |
|
|
5,588 |
|
|
22,867 |
|
|
36,797 |
| ||||
Comprehensive income |
|
$ |
8,928 |
|
|
$ |
5,588 |
|
|
$ |
22,658 |
|
|
$ |
36,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net income per share attributable to Newport Corporation: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
0.20 |
|
|
$ |
0.28 |
|
|
$ |
0.61 |
|
|
$ |
1.21 |
|
Diluted |
|
$ |
0.20 |
|
|
$ |
0.27 |
|
|
$ |
0.60 |
|
|
$ |
1.17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Shares used in per share calculations: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Basic |
|
38,264 |
|
|
37,543 |
|
|
38,072 |
|
|
37,342 |
| ||||
Diluted |
|
38,645 |
|
|
38,571 |
|
|
38,825 |
|
|
38,732 |
|
See accompanying notes.
NEWPORT CORPORATION
(In thousands, except share and per share data)
(Unaudited)
|
|
September 29, |
|
December 31, | ||||
|
|
2012 |
|
2011 | ||||
ASSETS |
|
|
|
|
|
| ||
Current assets: |
|
|
|
|
|
| ||
Cash and cash equivalents |
|
$ |
67,760 |
|
|
$ |
55,701 |
|
Restricted cash |
|
2,954 |
|
|
12,367 |
| ||
Marketable securities |
|
6,158 |
|
|
4,787 |
| ||
Accounts receivable, net of allowance for doubtful accounts of $1,595 and $2,532 as of September 29, 2012 and December 31, 2011, respectively |
|
94,010 |
|
|
97,690 |
| ||
Notes receivable |
|
2,680 |
|
|
2,091 |
| ||
Inventories |
|
110,940 |
|
|
112,968 |
| ||
Deferred income taxes |
|
29,809 |
|
|
30,339 |
| ||
Prepaid expenses and other current assets |
|
15,869 |
|
|
15,374 |
| ||
Total current assets |
|
330,180 |
|
|
331,317 |
| ||
|
|
|
|
|
|
| ||
Property and equipment, net |
|
84,198 |
|
|
89,873 |
| ||
Goodwill |
|
146,880 |
|
|
143,259 |
| ||
Deferred income taxes |
|
9,151 |
|
|
9,289 |
| ||
Intangible assets, net |
|
140,546 |
|
|
150,572 |
| ||
Other assets |
|
38,697 |
|
|
39,759 |
| ||
|
|
$ |
749,652 |
|
|
$ |
764,069 |
|
|
|
|
|
|
|
| ||
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
| ||
Current liabilities: |
|
|
|
|
|
| ||
Short-term borrowings, net |
|
$ |
34,421 |
|
|
$ |
45,149 |
|
Accounts payable |
|
29,806 |
|
|
30,856 |
| ||
Accrued payroll and related expenses |
|
27,800 |
|
|
36,914 |
| ||
Accrued expenses and other current liabilities |
|
41,960 |
|
|
39,800 |
| ||
Total current liabilities |
|
133,987 |
|
|
152,719 |
| ||
|
|
|
|
|
|
| ||
Long-term debt, net |
|
151,542 |
|
|
178,043 |
| ||
Accrued pension liabilities |
|
25,649 |
|
|
24,444 |
| ||
Deferred income taxes and other liabilities |
|
37,934 |
|
|
36,586 |
| ||
|
|
|
|
|
|
| ||
Commitments and contingencies |
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
Stockholders equity: |
|
|
|
|
|
| ||
Common stock, par value $0.1167 per share, 200,000,000 shares authorized; 38,286,818 and 37,634,403 shares issued and outstanding as of September 29, 2012 and December 31, 2011, respectively |
|
4,468 |
|
|
4,392 |
| ||
Capital in excess of par value |
|
437,175 |
|
|
431,606 |
| ||
Accumulated other comprehensive loss |
|
(6,504 |
) |
|
(5,989 |
) | ||
Accumulated deficit |
|
(36,369 |
) |
|
(59,751 |
) | ||
Total stockholders equity of Newport Corporation |
|
398,770 |
|
|
370,258 |
| ||
Non-controlling interests |
|
1,770 |
|
|
2,019 |
| ||
Total stockholders equity |
|
400,540 |
|
|
372,277 |
| ||
|
|
$ |
749,652 |
|
|
$ |
764,069 |
|
See accompanying notes.
NEWPORT CORPORATION
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
|
Nine Months Ended | ||||||
|
|
September 29, |
|
October 1, | ||||
|
|
2012 |
|
2011 | ||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
| ||
Net income |
|
$ |
23,181 |
|
|
$ |
45,183 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
| ||
Depreciation and amortization |
|
31,558 |
|
|
13,649 |
| ||
Amortization of discount on convertible subordinated notes |
|
12 |
|
|
3,135 |
| ||
Gain on sale of assets |
|
(6,414 |
) |
|
(619 |
) | ||
Foreign currency gain |
|
- |
|
|
(7,198 |
) | ||
Provision for losses on inventories |
|
5,177 |
|
|
4,461 |
| ||
Stock-based compensation expense |
|
6,265 |
|
|
4,679 |
| ||
Provision for doubtful accounts |
|
301 |
|
|
322 |
| ||
Loss on disposal of property and equipment |
|
233 |
|
|
95 |
| ||
Deferred income taxes |
|
1,306 |
|
|
271 |
| ||
Increase (decrease) in cash, net of acquisition, due to changes in: |
|
|
|
|
|
| ||
Accounts and notes receivable |
|
4,030 |
|
|
10,783 |
| ||
Inventories |
|
(3,798 |
) |
|
(12,918 |
) | ||
Prepaid expenses and other assets |
|
133 |
|
|
(259 |
) | ||
Accounts payable |
|
(1,133 |
) |
|
(9,800 |
) | ||
Accrued payroll and related expenses |
|
(9,384 |
) |
|
(6,185 |
) | ||
Accrued expenses and other liabilities |
|
2,699 |
|
|
3,201 |
| ||
Other long-term liabilities |
|
154 |
|
|
93 |
| ||
Net cash provided by operating activities |
|
54,320 |
|
|
48,893 |
| ||
|
|
|
|
|
|
| ||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
| ||
Purchase of property and equipment |
|
(8,297 |
) |
|
(7,628 |
) | ||
Restricted cash |
|
9,420 |
|
|
- |
| ||
Gain on sale of assets |
|
5,373 |
|
|
619 |
| ||
Business acquisition, net of cash acquired |
|
(8,939 |
) |
|
(12,516 |
) | ||
Purchase of marketable securities |
|
(4,216 |
) |
|
(101,773 |
) | ||
Proceeds from the sale of marketable securities |
|
2,804 |
|
|
203,744 |
| ||
Net cash provided by (used in) investing activities |
|
(3,855 |
) |
|
82,446 |
| ||
|
|
|
|
|
|
| ||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
| ||
Proceeds from long-term debt |
|
- |
|
|
2,963 |
| ||
Repayment of long-term debt and obligations under capital leases |
|
(20,443 |
) |
|
(131 |
) | ||
Proceeds from short-term borrowings |
|
9,031 |
|
|
16,859 |
| ||
Repayment of short-term borrowings |
|
(25,915 |
) |
|
(31,715 |
) | ||
Proceeds from the issuance of common stock under employee plans |
|
2,434 |
|
|
2,866 |
| ||
Tax withholding payments related to net share settlement of equity awards |
|
(3,053 |
) |
|
(3,435 |
) | ||
Net cash used in financing activities |
|
(37,946 |
) |
|
(12,593 |
) | ||
Impact of foreign exchange rate changes on cash balances |
|
(460 |
) |
|
(376 |
) | ||
Net increase in cash and cash equivalents |
|
12,059 |
|
|
118,370 |
| ||
Cash and cash equivalents at beginning of period |
|
55,701 |
|
|
90,992 |
| ||
Cash and cash equivalents at end of period |
|
$ |
67,760 |
|
|
$ |
209,362 |
|
|
|
|
|
|
|
| ||
Supplemental disclosures of cash flow information: |
|
|
|
|
|
| ||
Cash paid during the period for interest |
|
$ |
5,048 |
|
|
$ |
3,890 |
|
Cash paid during the period for income taxes, net |
|
$ |
4,865 |
|
|
$ |
1,580 |
|
Property and equipment accrued in accounts payable |
|
$ |
211 |
|
|
$ |
124 |
|
See accompanying notes.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
NOTE 1 BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements include the accounts of Newport Corporation and its wholly owned subsidiaries (collectively referred to as the Company) and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions of Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal and recurring accruals) considered necessary for a fair presentation have been included. All intercompany transactions and balances have been eliminated in consolidation.
The accompanying unaudited consolidated financial statements do not include certain footnotes and financial presentations normally required under generally accepted accounting principles (GAAP) and, therefore, should be read in conjunction with the consolidated financial statements and related notes contained in the Companys Annual Report on Form 10-K/A for the year ended December 31, 2011. The results for the interim periods are not necessarily indicative of the results the Company will have for the full year ending December 29, 2012. The December 31, 2011 balances reported herein are derived from the audited consolidated financial statements included in the Companys Annual Report on Form 10-K/A for the year ended December 31, 2011.
NOTE 2 RECENT ACCOUNTING PRONOUNCEMENTS
In July 2012, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment, which amends the guidance in Accounting Standards Codification (ASC) 350, IntangiblesGoodwill and Other. ASU No. 2012-02 allows, but does not require, companies to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired, and then use such assessment as a basis for determining whether it is necessary to perform the quantitative impairment test. ASU No. 2012-02 will be effective for fiscal years beginning after September 15, 2012, and early adoption is permitted but has not been elected by the Company. The adoption of ASU No. 2012-02 will not have a material impact on the Companys financial position or results of operations.
NOTE 3 MARKETABLE SECURITIES
All marketable securities of the Company were classified as available for sale and were recorded at market value using the specific identification method, and unrealized gains and losses are reflected in accumulated other comprehensive loss in the accompanying consolidated balance sheets. The aggregate fair value of available for sale securities and aggregate amount of unrealized gains and losses for available for sale securities at September 29, 2012 were as follows:
(In thousands) |
|
Aggregate |
|
Aggregate Amount of | ||||||
|
|
Fair Value |
|
Gains |
|
Losses | ||||
Equity securities |
|
$ |
1,830 |
|
$ |
91 |
|
$ |
- |
|
Certificates of deposit |
|
4,328 |
|
- |
|
- |
| |||
|
|
$ |
6,158 |
|
$ |
91 |
|
$ |
- |
|
The aggregate fair value of available for sale securities and aggregate amount of unrealized gains and losses for available for sale securities at December 31, 2011 were as follows:
(In thousands) |
|
Aggregate |
|
Aggregate Amount of | ||||||
|
|
Fair Value |
|
Gains |
|
Losses | ||||
Equity securities |
|
$ |
542 |
|
$ |
93 |
|
$ |
- |
|
Certificates of deposit |
|
4,245 |
|
- |
|
- |
| |||
|
|
$ |
4,787 |
|
$ |
93 |
|
$ |
- |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
The contractual maturities of certificates of deposit were as follows:
(In thousands) |
|
September 29, | ||
|
|
2012 | ||
0 1 Year |
|
$ |
4,328 |
|
1 2 Years |
|
- |
| |
2 3 Years |
|
- |
| |
3 5 Years |
|
- |
| |
5 10 Years |
|
- |
| |
More than 10 years |
|
- |
| |
|
|
$ |
4,328 |
|
The gross realized gains and losses on sales of available for sale securities were as follows:
|
|
Three Months Ended |
|
Nine Months Ended | |||||||||
(In thousands) |
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | |||||
|
|
2012 |
|
2011 |
|
2012 |
|
2011 | |||||
Gross realized gains |
|
$ |
- |
|
$ |
3 |
|
$ |
- |
|
$ |
69 |
|
Gross realized losses |
|
- |
|
- |
|
- |
|
- |
| ||||
|
|
$ |
- |
|
$ |
3 |
|
$ |
- |
|
$ |
69 |
|
NOTE 4 FAIR VALUE MEASUREMENTS
ASC 820-10, Fair Value Measurements and Disclosures, requires that for any assets and liabilities stated at fair value on a recurring basis in the Companys financial statements, the fair value of such assets and liabilities be measured based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Level 1 asset and liability values are derived from quoted prices in active markets for identical assets and liabilities and Level 2 asset and liability values are derived from quoted prices in inactive markets or based on other observable inputs.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
The Companys assets and liabilities measured at fair value on a recurring basis are categorized in the table below based upon their level within the fair value hierarchy as of September 29, 2012.
(In thousands) |
|
|
|
Fair Value Measurements at Reporting Date Using |
| ||||||||
Description |
|
September 29, 2012 |
|
Quoted Prices in |
|
Significant Other |
|
Significant |
| ||||
Assets: |
|
|
|
|
|
|
|
|
| ||||
Restricted Cash |
|
$ |
2,954 |
|
$ |
2,954 |
|
$ |
- |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
| ||||
Marketable securities: |
|
|
|
|
|
|
|
|
| ||||
Equity securities |
|
1,830 |
|
1,830 |
|
- |
|
- |
| ||||
Certificates of deposit |
|
4,328 |
|
- |
|
4,328 |
|
- |
| ||||
|
|
6,158 |
|
1,830 |
|
4,328 |
|
- |
| ||||
Derivative assets: |
|
|
|
|
|
|
|
|
| ||||
Forward contracts |
|
5 |
|
- |
|
5 |
|
- |
| ||||
Option contracts |
|
440 |
|
- |
|
440 |
|
- |
| ||||
|
|
445 |
|
- |
|
445 |
|
- |
| ||||
Pension assets not owned by plan |
|
6,594 |
|
- |
|
6,594 |
|
- |
| ||||
|
|
$ |
16,151 |
|
$ |
4,784 |
|
$ |
11,367 |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
| ||||
Liabilities: |
|
|
|
|
|
|
|
|
| ||||
Derivative liabilites: |
|
|
|
|
|
|
|
|
| ||||
Forward contracts |
|
$ |
54 |
|
$ |
- |
|
$ |
54 |
|
$ |
- |
|
Option contracts |
|
514 |
|
- |
|
514 |
|
- |
| ||||
|
|
$ |
568 |
|
$ |
- |
|
$ |
568 |
|
$ |
- |
|
The Companys assets and liabilities measured at fair value on a recurring basis are categorized in the table below based upon their level within the fair value hierarchy as of December 31, 2011.
(In thousands) |
|
|
|
Fair Value Measurements at Reporting Date Using |
| ||||||||
Description |
|
December 31, 2011 |
|
Quoted Prices in |
|
Significant Other |
|
Significant |
| ||||
Assets: |
|
|
|
|
|
|
|
|
| ||||
Restricted Cash |
|
$ |
12,367 |
|
$ |
12,367 |
|
$ |
- |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
| ||||
Marketable securities: |
|
|
|
|
|
|
|
|
| ||||
Equity securities |
|
542 |
|
542 |
|
- |
|
- |
| ||||
Certificates of deposit |
|
4,245 |
|
- |
|
4,245 |
|
- |
| ||||
|
|
4,787 |
|
542 |
|
4,245 |
|
- |
| ||||
Derivative assets: |
|
|
|
|
|
|
|
|
| ||||
Option contracts |
|
117 |
|
- |
|
117 |
|
- |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Pension assets not owned by plan |
|
6,572 |
|
- |
|
6,572 |
|
- |
| ||||
|
|
$ |
23,843 |
|
$ |
12,909 |
|
$ |
10,934 |
|
$ |
- |
|
Liabilities: |
|
|
|
|
|
|
|
|
| ||||
Derivative liabilites: |
|
|
|
|
|
|
|
|
| ||||
Forward contracts |
|
388 |
|
- |
|
388 |
|
- |
| ||||
Option contracts |
|
440 |
|
- |
|
440 |
|
- |
| ||||
|
|
$ |
828 |
|
$ |
- |
|
$ |
828 |
|
$ |
- |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
The Companys other financial instruments include short-term borrowings and long-term debt. The fair value of these financial instruments was estimated based on current rates for similar issues or on the current rates offered to the Company for debt of similar remaining maturities. The estimated fair values of these financial instruments were as follows:
|
|
September 29, 2012 |
|
December 31, 2011 | |||||||||
(In thousands) |
|
Carrying |
|
|
|
Carrying |
|
|
| ||||
|
|
Amount |
|
Fair Value |
|
Amount |
|
Fair Value | |||||
Short-term borrowings |
|
$ |
34,421 |
|
$ |
34,886 |
|
$ |
45,149 |
|
$ |
44,063 |
|
Long-term debt |
|
$ |
151,542 |
|
$ |
154,589 |
|
$ |
178,043 |
|
$ |
166,600 |
|
NOTE 5 ACQUISITION
On January 13, 2012, the Company acquired all of the outstanding capital stock of ILX Lightwave Corporation (ILX) by means of a merger of a wholly owned subsidiary of the Company with and into ILX. The total purchase price for the acquisition was $9.0 million. An initial purchase price of $9.3 million was paid in cash at closing, of which $1.2 million was deposited at closing into escrow until July 12, 2013, to secure certain indemnification and other obligations of the ILX securityholders. The purchase price was subsequently reduced by $0.3 million, based on a calculation of ILXs net assets at closing. The Company incurred $0.1 million in transaction costs, which have been expensed as incurred and are included in selling, general and administrative expenses in the accompanying consolidated statements of income and comprehensive income. This acquisition expanded the Companys optical power meter and fiber optic source product offerings, and added laser diode instrumentation and laser diode and light emitting diode (LED) burn-in, test and characterization systems to its product portfolio. ILX is now a part of the Companys Photonics and Precision Technologies (PPT) Division.
The consideration paid by the Company for the acquisition of ILX is allocated to the assets acquired, net of the liabilities assumed, based upon their estimated fair values as of the date of the acquisition. The excess of the purchase price over the estimated fair value of the assets acquired, net of the estimated fair value of the liabilities assumed, is recorded as goodwill. Below is a summary of the purchase price, assets acquired and liabilities assumed:
(In thousands) |
|
|
| |
Assets acquired and liabilities assumed: |
|
|
| |
Cash |
|
$ |
44 |
|
Accounts receivable |
|
1,224 |
| |
Inventories |
|
861 |
| |
Other assets |
|
587 |
| |
Goodwill |
|
3,762 |
| |
Developed technology |
|
2,800 |
| |
Customer relationships |
|
1,100 |
| |
Other intangible assets |
|
1,090 |
| |
Deferred income taxes |
|
(1,841 |
) | |
Other liabilities |
|
(644 |
) | |
|
|
$ |
8,983 |
|
The goodwill related to this acquisition has been allocated to the Companys PPT Division and will not be deductible for tax purposes, as this was a merger.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
The actual net sales and net income of ILX from January 13, 2012, the closing date of the acquisition, that were included in the Companys consolidated statements of income and comprehensive income for the three and nine months ended September 29, 2012 and October 1, 2011 are set forth in the table below. Also set forth in the table below are the pro forma net sales and net income of the Company during such periods, including the results of ILX as though the acquisition had occurred at the beginning of 2011. This supplemental pro forma financial information is presented for information purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had occurred as of the beginning of each reporting period.
|
|
Three Months Ended |
|
Nine Months Ended | |||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | |||||
(In thousands) |
|
2012 |
|
2011 |
|
2012 |
|
2011 | |||||
Actual: |
|
|
|
|
|
|
|
|
| ||||
Net sales |
|
$ |
1,903 |
|
$ |
- |
|
$ |
5,466 |
|
$ |
- |
|
Net income attributable to Newport Corporation |
|
$ |
419 |
|
$ |
- |
|
$ |
577 |
|
$ |
- |
|
Supplemental pro forma information: |
|
|
|
|
|
|
|
|
| ||||
Net sales |
|
$ |
142,881 |
|
$ |
127,893 |
|
$ |
453,743 |
|
$ |
389,876 |
|
Net income attributable to Newport Corporation |
|
$ |
7,643 |
|
$ |
10,726 |
|
$ |
23,821 |
|
$ |
45,085 |
|
For the purposes of determining pro forma net income, adjustments were made to actual net income of the Company for all periods presented in the table above. The pro forma net income assumes amortization of acquired intangible assets began at the beginning of 2011 rather than on January 13, 2012. The result is a net decrease in amortization expense of $6 thousand and $0.2 million for the three and nine months ended September 29, 2012, respectively, and an increase in amortization expense of $0.1 million and $0.7 million for the three and nine months ended October 1, 2011, respectively. In addition, $0.1 million in charges to cost of sales related to inventory that was marked up to fair value for purchase accounting was added back to pro forma net income for the nine months ended September 29, 2012 and subtracted from pro forma net income for the nine months ended October 1, 2011. Transaction costs totaling $0.4 million, which were incurred prior to the closing of the acquisition, are also excluded from pro forma net income.
NOTE 6 SUPPLEMENTAL BALANCE SHEET INFORMATION
Inventories
Inventories that are expected to be sold within one year are classified as current inventories and are included in inventories in the accompanying consolidated balance sheets. Such inventories were as follows:
(In thousands) |
|
September 29, |
|
December 31, | |||
|
|
2012 |
|
2011 | |||
Raw materials and purchased parts |
|
$ |
66,827 |
|
$ |
65,054 |
|
Work in process |
|
18,320 |
|
19,257 |
| ||
Finished goods |
|
25,793 |
|
28,657 |
| ||
Short-term inventories |
|
110,940 |
|
112,968 |
| ||
Inventories that are not expected to be sold within one year are classified as long-term inventories and are included in other assets in the accompanying consolidated balance sheets. Such inventories were as follows:
(In thousands) |
|
September 29, |
|
December 31, | |||
|
|
2012 |
|
2011 | |||
Raw materials and purchased parts |
|
$ |
3,650 |
|
$ |
3,306 |
|
Work in process |
|
- |
|
- |
| ||
Finished goods |
|
5,630 |
|
6,119 |
| ||
Long-term inventories |
|
9,280 |
|
9,425 |
| ||
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
Accrued Warranty Obligations
Unless otherwise stated in the Companys product literature or in its agreements with customers, products sold by the Companys PPT Division generally carry a one-year warranty from the original invoice date on all product materials and workmanship, other than filters and gratings products, which generally carry a 90-day warranty. Products of this division sold to original equipment manufacturer (OEM) customers generally carry longer warranties, typically 15 to 19 months. Products sold by the Companys Lasers Division carry warranties that vary by product and product component, but that generally range from 90 days to two years. In certain cases, such warranties for Lasers Division products are limited by either a set time period or a maximum amount of usage of the product, whichever occurs first. Products sold by the Companys Ophir Division generally carry a one-year warranty, except for laser beam profilers and dental CAD/CAM scanners, which generally carry a two-year warranty. Defective products will be either repaired or replaced, generally at the Companys option, upon meeting certain criteria. The Company accrues a provision for the estimated costs that may be incurred for warranties relating to a product (based on historical experience) as a component of cost of sales. Short-term accrued warranty obligations, which expire within one year, are included in accrued expenses and other current liabilities and long-term warranty obligations are included in deferred income taxes and other liabilities in the accompanying consolidated balance sheets. Short-term warranty obligations were $3.5 million and $4.3 million as of September 29, 2012 and December 31, 2011, respectively. As of September 29, 2012 and December 31, 2011, the amounts accrued for long-term warranty obligations were not material.
The activity in accrued warranty obligations was as follows:
|
|
Nine Months Ended | ||||||
(In thousands) |
|
September 29, |
|
October 1, | ||||
|
|
2012 |
|
2011 | ||||
Balance at beginning of year |
|
$ |
4,466 |
|
|
$ |
4,105 |
|
Additions charged to cost of sales |
|
2,011 |
|
|
2,853 |
| ||
Additions from acquisitions |
|
21 |
|
|
838 |
| ||
Warranty claims |
|
(2,881 |
) |
|
(2,922 |
) | ||
Balance at end of period |
|
$ |
3,617 |
|
|
$ |
4,874 |
|
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities were as follows:
(In thousands) |
|
September 29, |
|
December 31, | ||||
|
|
2012 |
|
2011 | ||||
Deferred revenue |
|
$ |
10,794 |
|
|
$ |
12,383 |
|
Accrued and deferred tax liabilities |
|
10,316 |
|
|
4,379 |
| ||
Deferred lease liability |
|
5,221 |
|
|
5,201 |
| ||
Short-term accrued warranty obligations |
|
3,525 |
|
|
4,342 |
| ||
Other |
|
12,104 |
|
|
13,495 |
| ||
|
|
$ |
41,960 |
|
|
$ |
39,800 |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss consisted of the following:
(In thousands) |
|
September 29, |
|
December 31, | ||||
|
|
2012 |
|
2011 | ||||
Cumulative foreign currency translation losses |
|
$ |
(6,295 |
) |
|
$ |
(5,804 |
) |
Unrecognized net pension losses |
|
(909 |
) |
|
(1,005 |
) | ||
Unrealized gains on marketable securities |
|
700 |
|
|
820 |
| ||
|
|
$ |
(6,504 |
) |
|
$ |
(5,989 |
) |
NOTE 7 INTANGIBLE ASSETS
Intangible assets were as follows:
(In thousands) |
|
September 29, |
|
December 31, | |||
|
|
2012 |
|
2011 | |||
Intangible assets subject to amortization: |
|
|
|
|
| ||
Developed technology, net of accumulated amortization of $10,082 and $6,903 as of September 29, 2012 and December 31, 2011, respectively |
|
$ |
50,684 |
|
$ |
51,159 |
|
Customer relationships, net of accumulated amortization of $24,852 and $16,500 as of September 29, 2012 and December 31, 2011, respectively |
|
54,336 |
|
61,609 |
| ||
In-process research and development, net of accumulated amortization of $37 and $0 as of September 29, 2012 and December 31, 2011 |
|
9,974 |
|
10,057 |
| ||
Other, net of accumulated amortization of $5,256 and $1,996 as of September 29, 2012 and December 31, 2011, respectively |
|
2,712 |
|
5,507 |
| ||
|
|
117,706 |
|
128,332 |
| ||
Intangible assets not subject to amortization: |
|
|
|
|
| ||
Trademarks and trade names |
|
22,840 |
|
22,240 |
| ||
Intangible assets, net |
|
$ |
140,546 |
|
$ |
150,572 |
|
Developed technology is amortized on a straight line basis over 10 to 20 years, depending on the life of the product technology. Intangible assets related to customer relationships are primarily amortized over a period of up to 10 years on an accelerated basis. In-process research and development is amortized on a straight line basis over the products estimated useful life upon completion of the technology. Other intangible assets include acquired backlog, product trademarks and trade names, non-competition agreements and defensible assets. With the exception of product trademarks and trade names, such assets are amortized on a straight line basis over a period of three months to 10 years, depending on the asset. Trademarks and trade names associated with products are amortized on a straight line basis over the estimated remaining life of the product technology, which ranges from 10 to 20 years. Trademarks and trade names associated with a business have indefinite lives and are not amortized.
Amortization expense related to intangible assets totaled $4.6 million and $14.8 million for the three and nine months ended September 29, 2012, respectively, and $1.3 million and $2.8 million for the three and nine months ended October 1, 2011, respectively.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
Estimated aggregate amortization expense for future fiscal years is as follows:
(In thousands) |
|
Estimated | ||
2012 (remaining) |
|
$ |
4,461 |
|
2013 |
|
15,859 |
| |
2014 |
|
15,508 |
| |
2015 |
|
13,987 |
| |
2016 |
|
11,635 |
| |
Thereafter |
|
46,985 |
| |
|
|
$ |
108,435 |
|
The Company has excluded $9.3 million of amortization expense related to certain in-process research and development projects from the table above, as it was uncertain as of September 29, 2012 when the technology will be completed and when the amortization will begin.
NOTE 8 INTEREST AND OTHER EXPENSE, NET
Interest and other expense, net, was as follows:
|
|
Three Months Ended |
|
Nine Months Ended | ||||||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | ||||||||
(In thousands) |
|
2012 |
|
2011 |
|
2012 |
|
2011 | ||||||||
Interest expense |
|
$ |
(1,948 |
) |
|
$ |
(2,658 |
) |
|
$ |
(6,191 |
) |
|
$ |
(6,859 |
) |
Interest and dividend income |
|
55 |
|
|
99 |
|
|
158 |
|
|
390 |
| ||||
Derivative loss |
|
(633 |
) |
|
- |
|
|
(450 |
) |
|
- |
| ||||
Bank and portfolio asset management fees |
|
(212 |
) |
|
(196 |
) |
|
(540 |
) |
|
(621 |
) | ||||
Other income (expense), net |
|
656 |
|
|
407 |
|
|
(74 |
) |
|
713 |
| ||||
|
|
$ |
(2,082 |
) |
|
$ |
(2,348 |
) |
|
$ |
(7,097 |
) |
|
$ |
(6,377 |
) |
NOTE 9 STOCK-BASED COMPENSATION
During the nine months ended September 29, 2012, the Company granted 0.5 million restricted stock units and 0.4 million stock-settled stock appreciation rights with weighted average grant date fair values of $17.11 and $7.92, respectively.
The total stock-based compensation expense included in the Companys consolidated statements of income and comprehensive income was as follows:
|
|
Three Months Ended |
|
Nine Months Ended | |||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | |||||
(In thousands) |
|
2012 |
|
2011 |
|
2012 |
|
2011 | |||||
Cost of sales |
|
$ |
189 |
|
$ |
133 |
|
$ |
490 |
|
$ |
354 |
|
Selling, general and administrative expenses |
|
1,767 |
|
1,210 |
|
5,075 |
|
3,807 |
| ||||
Research and development expense |
|
217 |
|
166 |
|
700 |
|
518 |
| ||||
|
|
$ |
2,173 |
|
$ |
1,509 |
|
$ |
6,265 |
|
$ |
4,679 |
|
At September 29, 2012, the total compensation cost related to unvested stock-based awards granted to employees, officers and directors under the Companys stock-based benefit plans that had not yet been recognized was $11.7
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
million (net of estimated forfeitures of $2.3 million). This future compensation expense will be amortized over a weighted-average period of 1.5 years using the straight-line attribution method. The actual compensation expense that the Company will recognize in the future related to unvested stock-based awards outstanding at September 29, 2012 will be adjusted for actual forfeitures and will be adjusted based on the Companys determination as to the extent to which performance conditions applicable to any stock-based awards have been or will be achieved.
At September 29, 2012, 1.1 million stock options with a weighted-average exercise price of $13.38 per share, intrinsic value of $7 thousand and remaining contractual term of 1.4 years were outstanding and were exercisable. At September 29, 2012, 1.6 million stock-settled stock appreciation rights with a weighted-average base value of $11.18 per share, intrinsic value of $4.3 million and remaining contractual term of 4.8 years were outstanding, and 0.9 million stock-settled stock appreciation rights with a weighted-average base value of $7.11 per share, intrinsic value of $4.3 million and remaining contractual term of 3.9 years were exercisable.
NOTE 10 DEBT AND LINES OF CREDIT
Total short-term debt was as follows:
(In thousands) |
|
September 29, |
|
December 31, |
| ||
|
|
2012 |
|
2011 |
| ||
|
|
|
|
|
| ||
Japanese revolving lines of credit |
|
$ |
5,776 |
|
$ |
5,539 |
|
Japanese receivables financing facilities |
|
1,068 |
|
1,262 |
| ||
Convertible notes due February 2012 |
|
- |
|
12,356 |
| ||
Total short-term borrowings |
|
$ |
6,844 |
|
$ |
19,157 |
|
Total long-term debt was as follows:
(In thousands) |
|
September 29, |
|
December 31, | |||
|
|
2012 |
|
2011 | |||
|
|
|
|
|
| ||
Japanese private placement bonds due June 2014 |
|
$ |
2,567 |
|
$ |
2,576 |
|
Japanese loans due through November 2016 |
|
1,329 |
|
1,463 |
| ||
Austrian loans |
|
- |
|
4,158 |
| ||
Israeli loans due through October 2015 |
|
4,098 |
|
10,838 |
| ||
U.S. term loan due October 2016 |
|
171,125 |
|
185,000 |
| ||
Total long-term debt |
|
179,119 |
|
204,035 |
| ||
Current portion of long-term debt |
|
27,577 |
|
25,992 |
| ||
Total long-term debt, less current portion |
|
$ |
151,542 |
|
$ |
178,043 |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
NOTE 11 NET INCOME PER SHARE
The following table sets forth the computation of basic and diluted net income per share:
|
|
Three Months Ended |
|
Nine Months Ended | |||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | |||||
(In thousands, except per share data) |
|
2012 |
|
2011 |
|
2012 |
|
2011 | |||||
|
|
|
|
|
|
|
|
|
| ||||
Net income attributable to Newport Corporation |
|
$ |
7,636 |
|
$ |
10,502 |
|
$ |
23,382 |
|
$ |
45,183 |
|
|
|
|
|
|
|
|
|
|
| ||||
Shares: |
|
|
|
|
|
|
|
|
| ||||
Weighted average shares outstanding - basic |
|
38,264 |
|
37,543 |
|
38,072 |
|
37,342 |
| ||||
Dilutive potential common shares, using treasury stock method |
|
381 |
|
1,028 |
|
753 |
|
1,390 |
| ||||
Weighted average shares outstanding - diluted |
|
38,645 |
|
38,571 |
|
38,825 |
|
38,732 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net income per share attributable to Newport Corporation: |
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
0.20 |
|
$ |
0.28 |
|
$ |
0.61 |
|
$ |
1.21 |
|
Diluted |
|
$ |
0.20 |
|
$ |
0.27 |
|
$ |
0.60 |
|
$ |
1.17 |
|
For the three and nine months ended September 29, 2012, a total of 1.0 million stock options and stock-settled stock appreciation rights, and for the three and nine months ended October 1, 2011, a total of 0.7 million stock options and stock-settled stock appreciation rights and a total of 0.6 million stock options and stock-settled stock appreciation rights, respectively, were excluded from the computations of diluted net income per share, as their exercise prices (or base values) exceeded the average market price of the Companys common stock during such periods, and their inclusion would have been antidilutive. For the three and nine months ended September 29, 2012, 0.2 million restricted stock units and for the three and nine months ended October 1, 2011, 0.3 million restricted stock units were excluded from the computations of diluted net income per share, as the amount of unrecognized future compensation expense associated with these restricted stock units would have resulted in assumed proceeds in excess of the amount required to repurchase the underlying shares under the treasury stock method, and, therefore, their inclusion would have been antidilutive. For the three and nine months ended September 29, 2012, an additional 0.4 million performance-based restricted stock units were excluded from the computations of diluted net income per share, as the performance criteria for their vesting had not been met as of the end of such period.
NOTE 12 INCOME TAXES
Under ASC 740-270, Income Taxes Interim Reporting, the Company is required to evaluate and make any necessary adjustments to its effective tax rate each quarter as new information is obtained that may affect the assumptions used to estimate its annual effective tax rate. The Companys assumptions relate to factors such as the projected level and mix of pre-tax earnings in the various tax jurisdictions in which it operates, valuation allowances against deferred tax assets, the recognition or derecognition of tax benefits related to uncertain tax positions, expected utilization of tax credits and changes in or the interpretation of tax laws in jurisdictions in which the Company conducts business. In addition, jurisdictions for which the Company has projected losses for the year, or a year-to-date loss, where no tax benefit can be recognized, are excluded from the calculation of the estimated annual effective tax rate. Changes in the assumptions and the inclusion or exclusion of certain jurisdictions could result in a higher or lower effective tax rate during a particular quarter.
Deferred income taxes are recognized for the future tax consequences of temporary differences using enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Temporary differences include the difference between the financial statement carrying amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carryforwards. The effect of a change in tax rates on deferred taxes is recognized in income in the period that includes the enactment date. In accordance with the provisions of ASC 740, a valuation allowance for deferred tax assets is recorded to the extent the Company cannot determine that the ultimate realization of the net deferred tax assets is
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
more likely than not. Realization of deferred tax assets is principally dependent upon the achievement of future taxable income, the estimation of which requires significant management judgment. During the first quarter of 2012, the Company released $1.4 million of its valuation allowance related to certain deferred tax assets due to the expected recovery of certain investments and capital loss carryovers. During the third quarter of 2012, the Company released $0.4 million of its valuation allowance related to certain deferred tax assets due to the recovery of certain other investments. As of September 29, 2012, the Company could not determine that it is more likely than not that deferred tax assets related to certain foreign net operating loss carryforwards and other miscellaneous domestic and foreign deferred tax assets would be realized. Therefore, the Company has maintained a valuation allowance of $1.3 million against certain deferred tax assets.
The Company utilizes ASC 740-10-25, Income Taxes Recognition, which requires income tax positions to meet a more-likely-than-not recognition threshold to be recognized in the financial statements. Under ASC 740-10-25, tax positions that previously failed to meet the more-likely-than-not threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold should be derecognized in the first subsequent financial reporting period in which that threshold is no longer met. As a multi-national corporation, the Company is subject to taxation in many jurisdictions, and the calculation of its tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in various taxing jurisdictions. If the Company ultimately determines that the payment of these liabilities will be unnecessary, it reverses the liability and recognizes a tax benefit during the period in which it determines the liability no longer applies. Conversely, the Company records additional tax charges in a period in which it determines that a recorded tax liability is less than it expects the ultimate assessment to be. As a result of these adjustments, the Companys effective tax rate in a given financial statement period could be materially affected. As of September 29, 2012, the Company had $16.4 million of gross unrecognized tax benefits and a total of $13.3 million of net unrecognized tax benefits, which, if recognized, would affect the effective tax rate. Interest and penalties related to unrecognized tax benefits were not significant for the three and nine months ended September 29, 2012.
NOTE 13 STOCKHOLDERS EQUITY TRANSACTIONS
In May 2008, the Board of Directors of the Company approved a share repurchase program, authorizing the purchase of up to 4.0 million shares of the Companys common stock. No purchases were made under this program during the nine months ended September 29, 2012. As of September 29, 2012, 3.9 million shares remained available for purchase under the program. However, the terms of the Companys senior secured credit facility entered into in October 2011 restrict the Companys ability to purchase additional shares under this program during the term of such facility.
In March 2012, the Company cancelled 0.2 million restricted stock units in payment by employees of taxes owed upon the vesting of restricted stock units issued to them under the Companys stock incentive plans. The value of these restricted stock units totaled $3.1 million at the time they were cancelled.
NOTE 14 DEFINED BENEFIT PENSION PLANS
The Company has defined benefit pension plans covering substantially all full-time employees in France, Germany, Israel and Japan. In addition, the Company has certain pension liabilities relating to former employees of the Company in the United Kingdom. The German plan is unfunded, as permitted under the plan and applicable laws. For financial reporting purposes, the calculation of net periodic pension costs is based upon a number of actuarial assumptions, including a discount rate for plan obligations, an assumed rate of return on pension plan assets and an assumed rate of compensation increase for employees covered by the plan. All of these assumptions are based upon managements judgment, considering all known trends and uncertainties. Actual results that differ from these assumptions would impact future expense recognition and the cash funding requirements of the Companys pension plans.
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
Net periodic benefit costs for the plans in aggregate included the following components:
|
|
Three Months Ended |
|
Nine Months Ended | ||||||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | ||||||||
(In thousands) |
|
2012 |
|
2011 |
|
2012 |
|
2011 | ||||||||
Service cost |
|
$ |
713 |
|
|
$ |
177 |
|
|
$ |
2,240 |
|
|
$ |
517 |
|
Interest cost on benefit obligations |
|
180 |
|
|
209 |
|
|
548 |
|
|
621 |
| ||||
Expected return on plan assets |
|
(57 |
) |
|
(60 |
) |
|
(171 |
) |
|
(177 |
) | ||||
Amortization of net loss |
|
38 |
|
|
10 |
|
|
114 |
|
|
29 |
| ||||
|
|
$ |
874 |
|
|
$ |
336 |
|
|
$ |
2,731 |
|
|
$ |
990 |
|
NOTE 15 BUSINESS SEGMENT INFORMATION
The operating segments reported below are the segments of the Company for which separate financial information is available and for which operating results are evaluated regularly by the Chief Executive Officer, who is the chief operating decision maker, in deciding how to allocate resources and in assessing performance. The Company develops, manufactures and markets its products within three distinct business segments, its PPT Division, its Lasers Division and its Ophir Division.
The Company measured income reported for each business segment, which included only those costs that were directly attributable to the operations of that segment, and excluded certain unallocated operating expenses, such as corporate overhead and intangible asset amortization, unallocated gains, interest and other expense, net, and income taxes.
(In thousands) |
|
Photonics and |
|
Lasers |
|
Ophir |
|
Total |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Three months ended September 29, 2012: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
76,154 |
|
$ |
42,545 |
|
$ |
24,182 |
|
$ |
142,881 |
|
Segment income |
|
$ |
16,985 |
|
$ |
3,944 |
|
$ |
2,501 |
|
$ |
23,430 |
|
|
|
|
|
|
|
|
|
|
| ||||
Three months ended October 1, 2011: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
78,939 |
|
$ |
46,659 |
|
$ |
- |
|
$ |
125,598 |
|
Segment income |
|
$ |
17,879 |
|
$ |
3,182 |
|
$ |
- |
|
$ |
21,061 |
|
|
|
|
|
|
|
|
|
|
| ||||
Nine months ended September 29, 2012: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
238,066 |
|
$ |
136,506 |
|
$ |
79,131 |
|
$ |
453,703 |
|
Segment income |
|
$ |
51,967 |
|
$ |
13,478 |
|
$ |
6,671 |
|
$ |
72,116 |
|
|
|
|
|
|
|
|
|
|
| ||||
Nine months ended October 1, 2011: |
|
|
|
|
|
|
|
|
| ||||
Sales to external customers |
|
$ |
246,518 |
|
$ |
137,623 |
|
$ |
- |
|
$ |
384,141 |
|
Segment income |
|
$ |
58,290 |
|
$ |
12,031 |
|
$ |
- |
|
$ |
70,321 |
|
NEWPORT CORPORATION
Notes to Consolidated Financial Statements
September 29, 2012
The following table reconciles segment income to consolidated income before income taxes:
|
|
Three Months Ended |
|
Nine Months Ended | ||||||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, | ||||||||
(In thousands) |
|
2012 |
|
2011 |
|
2012 |
|
2011 | ||||||||
Segment income |
|
$ |
23,430 |
|
|
$ |
21,061 |
|
|
$ |
72,116 |
|
|
$ |
70,321 |
|
Gain on sale of investments |
|
950 |
|
|
- |
|
|
6,248 |
|
|
- |
| ||||
Foreign currency translation gain from dissolution of subsidiary |
|
- |
|
|
- |
|
|
- |
|
|
7,198 |
| ||||
Unallocated operating expenses |
|
(10,811 |
) |
|
(6,847 |
) |
|
(37,942 |
) |
|
(22,404 |
) | ||||
Interest and other expense, net |
|
(2,082 |
) |
|
(2,348 |
) |
|
(7,097 |
) |
|
(6,377 |
) | ||||
|
|
$ |
11,487 |
|
|
$ |
11,866 |
|
|
$ |
33,325 |
|
|
$ |
48,738 |
|
NOTE 16 GAIN ON SALE OF INVESTMENTS
The Company holds equity interests in privately-held corporations, which were accounted for using the cost method. During previous years, the Company had reduced the carrying value of these investments to zero due to the corporations poor financial condition. In the second quarter of 2012, one of these corporations was acquired in a merger transaction, and the Company received $5.3 million for its interest as a result of the acquisition. In the third quarter of 2012, another of these corporations redeemed its shares from the Company for $1.0 million, which amount was received during the fourth quarter of 2012.
NOTE 17 LEGAL PROCEEDINGS
On January 21, 2011, two former employees of Spectra-Physics, together with two of their children, brought suit against Spectra-Physics and the Company in the Superior Court for Santa Clara County, California. In the action, the plaintiffs allege that between 1975 and 1985 they and their unborn children were exposed to toxic chemicals during their work at Spectra-Physics, and that Spectra-Physics failed to warn them about dangers associated with the chemicals and failed to implement adequate safeguards to protect them from the chemicals, resulting in injuries to them and their unborn children.
In May 2012, the plaintiffs filed their response to the Companys demand for a statement of damages, in which they indicated they are seeking an aggregate of $25 million in general damages, $6.5 million in special damages and exemplary and punitive damages to be established by the trier of fact. The Company disputes that the plaintiffs are entitled to any damages, and it continues to believe that the plaintiffs claims are without merit and intends to vigorously defend its position. Discovery in this action is ongoing, and the Company has filed motions for summary judgment of certain of the plaintiffs claims based on the statute of limitations applicable to such claims, which motions are scheduled to be heard in December 2012. Therefore, at this stage, the Company is unable to provide an estimate of the potential exposure or the likelihood of a favorable or unfavorable outcome in this action.
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Managements Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our unaudited consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and in conjunction with our Annual Report on Form 10-K/A for the year ended December 31, 2011 previously filed with the SEC. This discussion contains descriptions of our expectations regarding future trends affecting our business. Words such as anticipate, believe, can, continue, could, estimate, expect, intend, may, plan, potential, predict, should, will, would, or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance or condition, trends in our business, or other characterizations of future events or circumstances are forward-looking statements. These forward-looking statements and other forward-looking statements made elsewhere in this report are made in reliance upon safe harbor provisions in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of several factors, including, but not limited to those factors set forth and discussed elsewhere in this Quarterly Report on Form 10-Q and in Item 1 (Business) and Item 1A (Risk Factors) of Part I, and Item 7 (Managements Discussion and Analysis of Financial Condition and Results of Operations) of Part II, of our Annual Report on Form 10-K/A for the year ended December 31, 2011. In light of the significant uncertainties inherent in the forward-looking information included in this report, the inclusion of this information should not be regarded as a representation by us or any other person that our objectives or plans will be achieved and readers are cautioned not to place undue reliance on such forward-looking information. Except as required by law, we undertake no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
Overview
We are a global supplier of advanced-technology products and systems, including lasers, photonics instrumentation, precision positioning and vibration isolation products and systems, optical components, subassemblies and subsystems, three-dimensional non-contact measurement equipment and advanced automated manufacturing systems. Our products are used worldwide in industries including scientific research, defense/security, microelectronics, life and health sciences and industrial markets. We operate within three distinct business segments, our Photonics and Precision Technologies (PPT) Division, our Lasers Division and our Ophir Division. All of our divisions offer a broad array of advanced technology products and services to original equipment manufacturer (OEM) and end-user customers across a wide range of applications in all of our targeted end markets.
The following is a discussion and analysis of certain factors that have affected our results of operations and financial condition during the periods included in the accompanying consolidated financial statements.
Critical Accounting Policies and Estimates
The preparation of our financial statements requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. We evaluate these estimates and assumptions on an ongoing basis. We base our estimates on our historical experience and on various other factors which we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of certain expenses that are not readily apparent from other sources. The accounting policies that involve the most significant judgments, assumptions and estimates used in the preparation of our financial statements are those related to revenue recognition, allowances for doubtful accounts, pension liabilities, inventory reserves, warranty obligations, asset impairment, income taxes and stock-based compensation. The judgments, assumptions and estimates used in these areas by their nature involve risks and uncertainties, and in the event that any of them prove to be inaccurate in any material respect, it could have a material effect on our reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. A summary of these critical accounting policies is included in Item 7 (Managements Discussion and Analysis of Financial Condition and Results of Operations) of Part II, of our Annual Report on Form 10-K/A for the fiscal year ended
December 31, 2011. There have been no material changes to the critical accounting policies disclosed in our Annual Report on Form 10-K/A.
Acquisition
On January 13, 2012, we acquired all of the outstanding capital stock of ILX Lightwave Corporation (ILX) by means of a merger of our wholly owned subsidiary with and into ILX. The total purchase price for the acquisition was $9.0 million. An initial purchase price of $9.3 million was paid in cash at closing, of which $1.2 million was deposited at closing into escrow until July 12, 2013, to secure certain indemnification and other obligations of the ILX securityholders. The purchase price was subsequently reduced by $0.3 million, based on a calculation of ILXs net assets at closing. We incurred $0.1 million in transaction costs, which have been expensed as incurred and are included in selling, general and administrative expenses in the accompanying consolidated statements of income and comprehensive income. This acquisition expanded our optical power meter and fiber optic source product offerings, and added laser diode instrumentation and laser diode and light emitting diode (LED) burn-in, test and characterization systems to our product portfolio. ILX is now a part of our PPT Division.
The consideration paid for the acquisition of ILX is allocated to the assets acquired, net of the liabilities assumed, based upon their estimated fair values as of the date of the acquisition. The excess of the purchase price over the estimated fair value of the assets acquired, net of the estimated fair value of the liabilities assumed, is recorded as goodwill. Below is a summary of the purchase price, assets acquired and liabilities assumed:
(In thousands) |
|
|
| |
Assets acquired and liabilities assumed: |
|
|
| |
Cash |
|
$ |
44 |
|
Accounts receivable |
|
1,224 |
| |
Inventories |
|
861 |
| |
Other assets |
|
587 |
| |
Goodwill |
|
3,762 |
| |
Developed technology |
|
2,800 |
| |
Customer relationships |
|
1,100 |
| |
Other intangible assets |
|
1,090 |
| |
Deferred income taxes |
|
(1,841 |
) | |
Other liabilities |
|
(644 |
) | |
|
|
$ |
8,983 |
|
The goodwill related to this acquisition has been allocated to our PPT Division and will not be deductible for tax purposes, as this was a merger.
Goodwill
During 2011, we acquired multiple businesses, which resulted in us recording goodwill in our Lasers Division and Ophir Division of $6.1 million and $67.8 million, respectively. Political deadlock in Congress due to ideological differences and the current presidential election year in the U.S., as well as the prospect of automatic spending cuts scheduled to take effect in January 2013 absent Congressional action, have created enormous uncertainty in the levels of Federal spending on research and defense programs for 2013. As a result, many research customers have reduced their spending for any new research projects in 2012 that would extend into 2013 until they have better visibility as to their 2013 funding levels. Similarly, many U.S. defense contractors have reduced their spending levels in 2012 until they have better visibility as to defense procurement levels in 2013. Further, the uncertainty caused by the massive overhaul of the U.S. healthcare system under recent legislation, as well as the possibility for repeal of that legislation in the future, have caused many customers in the life and health sciences market to halt, delay or reduce their spending until they have better visibility as to the future regulatory environment. As a result, our actual 2012 sales, and in particular the sales of our Ophir Division, are below the levels that we had originally forecasted. These sales levels and other factors could negatively impact our evaluation of the goodwill associated with our business. We believe that the assumptions we use in evaluating the goodwill associated with our business
are reasonable, however we may be required to recognize a goodwill impairment charge in the future as a result of subsequent changes to the factors underlying such assumptions.
Stock-Based Compensation
During the nine months ended September 29, 2012, we granted 0.5 million restricted stock units and 0.4 million stock-settled stock appreciation rights with weighted average grant date fair values of $17.11 and $7.92, respectively.
The total stock-based compensation expense included in our consolidated statements of income and comprehensive income was as follows:
|
|
Three Months Ended |
|
Nine Months Ended |
| ||||||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, |
| ||||
(In thousands) |
|
2012 |
|
2011 |
|
2012 |
|
2011 |
| ||||
Cost of sales |
|
$ |
189 |
|
$ |
133 |
|
$ |
490 |
|
$ |
354 |
|
Selling, general and administrative expenses |
|
1,767 |
|
1,210 |
|
5,075 |
|
3,807 |
| ||||
Research and development expense |
|
217 |
|
166 |
|
700 |
|
518 |
| ||||
|
|
$ |
2,173 |
|
$ |
1,509 |
|
$ |
6,265 |
|
$ |
4,679 |
|
Results of Operations for the Three and Nine Months Ended September 29, 2012 and October 1, 2011
The following table presents our results of operations for the periods indicated as a percentage of net sales:
|
|
Percentage of Net Sales |
| ||||||
|
|
Three Months Ended |
|
Nine Months Ended |
| ||||
|
|
September 29, |
|
October 1, |
|
September 29, |
|
October 1, |
|
|
|
2012 |
|
2011 |
|
2012 |
|
2011 |
|
Net sales |
|
100.0 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
Cost of sales |
|
56.0 |
|
55.6 |
|
56.4 |
|
54.9 |
|
Gross profit |
|
44.0 |
|
44.4 |
|
43.6 |
|
45.1 |
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
26.1 |
|
24.2 |
|
27.2 |
|
24.4 |
|
Research and development expense |
|
9.0 |